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Abstract
Rapeseed is one of the world’s major oilseeds, and rapeseed oil is produced by pressing of the seeds. This process
results in the production of a low-economic-value by-product, rapeseed meal, which is commonly used as animal feed.
Rapeseed meal is rich in bioactive phenolic compounds, including sinapinic acid (SA) and protocatechuic acid (PCA).
Isolation of these bioactive compounds from a by-product of rapeseed oil production is largely in agreement with the
current concept of the circular economy and total utilisation of crop harvest using a biorefinery approach. In this review,
current information concerning traditional and novel methods to isolate phenolic compounds – including SA and PCA –
from rapeseed meal, along with in vitro and in vivo studies concerning the bioactivity of SA and PCA and their associated
health effects, is collated. These health effects include anti-inflammatory, anti-cancer, anti-diabetes activities, along with
histone deacetylase inhibition and protective cardiovascular, neurological and hepatic effects. The traditional extraction
methods include use of solvents and/or enzymes. However, a need for simpler, more efficient methodologies has led to
the development of novel extraction processes, including microwave-assisted, ultrasound-assisted, pulsed electric field
and high-voltage electrical discharge extraction processes.
Keywords
cardiovascular health • diabetes • protocatechuic and sinapinic acid

Introduction
Rapeseed is a globally valuable crop, and its production has
steadily grown over the past 20 yr. Rapeseed is cultivated
in China, India, Canada and Europe; however, in terms of
rapeseed production, Europe is the largest producer (Carre,
2014). In the year 2013/2014, the European Union (EU)
produced 9.93 million t of rapeseed oil, while China produced
6.58 million t (List, 2015). A by-product of the rapeseed oil
industry, rapeseed meal contains bioactive constituents,
such as the phenolics sinapinic acid (SA) and protocatechuic
acid (PCA), which have potential uses as functional food
ingredients and for use in cosmetic and pharmaceutical
applications. Improving and developing methods to isolate
phenolic compounds from rapeseed meal could enhance the
economic value of this resource. The isolation of phenolics
from rapeseed meal encompasses the idea of a “circular
economy”, whereby resources that would otherwise be
considered waste are recycled into products (Velis, 2015).
Traditional methods of isolating phenolics from rapeseed
meal include organic solvent and enzymatic extraction;

however, this can require large volumes of solvent, while the
associated toxicity of certain organic solvents such as methanol
makes them unsuitable for use in final food applications. This
has encouraged the development of novel isolation methods
such as ultrasound-assisted (UAE), microwave-assisted (MAE),
high-voltage electrical discharge (HVED) and pulsed electric field
(PEF) extraction processes (Teh and Birch, 2014; Barba et al.,
2015; Teh et al., 2015). In the first part of this review, existing
and novel methods of isolating these phenolic compounds from
rapeseed meal are examined. The second part of the review
focusses on the diverse bioactive properties of these phenolics,
which could make them potentially useful in improving human
health.
Poor diet plays a role in the development of major diseases such
as heart disease, diabetes and cancer. Consumption of a diet
rich in vegetables is strongly implicated as a protective factor
against such diseases, due to the presence of polyphenols or
phenolic compounds. Clinical trials regarding the use of dietary
phenolic compounds for the prevention of colorectal cancer
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revealed that the amount required to exert their effects exceeds
what is obtainable from dietary intake alone (Nunez-Sanchez
et al., 2015). In this review, diverse and potentially important
physiological roles of SA and PCA in terms of human health
and disease are discussed.

Rapeseed meal and oil production
Rapeseed meal is a by-product of the rapeseed de-oiling
process, with the majority of phenolic compounds remaining
in the meal after extraction of the oil (Figure 1). Traditionally,
the production of rapeseed oil involves mechanical extraction
by pre-pressing and extrusion of rapeseeds, followed by
extraction with solvents such as food grade hexane. The
processing of oil and meal involves various steps, including
seed pre-conditioning and flaking, seed cooking, pressing
and solvent extraction, followed by the removal of solvent
and toasting. Some small-scale facilities do not use solvents
to extract rapeseed oil, using only mechanical extraction
(Booth, 2004). Although food grade solvents are used during
extraction of food grade oils, further refinement of the rapeseed
oil is necessary to make it more palatable and suitable for
human consumption. Refinement steps include the removal of
unwanted components, including phospholipids and free fatty
acids, which can be achieved by either physical or chemical
means. Chemical methods include either water or acid
degumming and alkali refining, while the physical process
involves “steam distillation”.

Phenolic compounds in rapeseed
Rapeseed is reported to contain more phenolic compounds
than any other oilseed plant (Lomascolo et al., 2012).
Reports suggest that rapeseed contains 240–590 μg/g of
SA, while rapeseed cake (an initial by-product produced by
crushing the rapeseeds to remove the oil) contains 170–
454 μg/g of SA (Nićiforović and Abramovič, 2014). PCA is
also found in rapeseed, with concentrations ranging from 28
μg/g to 612 μg/g in rapeseed hulls (Liu et al., 2012). Phenolic
compounds present in rapeseed can be categorised into
various subgroups: phenolic acids, lignans, stilbenes,
flavonoids, isoflavonoids and complex phenolic polymers
such as tannins (Vuorela, 2005). Phenolic acids tend to be
found in a soluble form, conjugated with sugars or organic
acids, and are usually constituents of more complex structures
such as lignans and hydrolysable tannins (Cheynier et al.,
2013). In rapeseed, the main phenolic compounds are
derivatives of hydroxycinnamic acid (Cvjetko. et al., 2009).
The biosynthetic origin of both benzoic and cinnamic acid
derivatives is the aromatic amino acid l-phenylalanine,
which itself is the end product of the shikimate pathway.
The preceding conversion of l-phenylalanine to various
hydroxycinnamic acids involves a three-step sequence,
referred to as the “general phenylpropanoid metabolism”
(Robbins, 2003). Phenolic compounds found in rapeseed
mainly exist in the esterified form. Sinapine, which is the
choline ester of SA, is the main phenolic ester in rapeseed.

Figure 1. Rapeseed de-oiling process and the phenolics remaining in the meal after extraction.
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However, SA can also be esterified to other phenolic acids,
sugars or kaempferols (Vuorela, 2005). SA comprises
70%–96% of the esterified phenolic acids in rapeseed meal,
while PCA is present in small quantities in rapeseed flours
(Shahidi and Naczk, 1992). Sinapine plays an important
role in rapeseed, acting as storage for both SA and choline
in young plants (Kozlowska et al., 1990). As the seeds
mature, some of the sinapine is enzymatically hydrolysed
by sinapine esterase to choline and free SA (Tzagoloff,
1963). Apart from the esterified forms, free phenolic acids
can also be found in rapeseed, comprising up to 15% of the
total phenolics in rapeseed meal. SA comprises 65%–85%
of free phenolic acids in defatted rapeseed meals, with PCA
also present in small quantities (Naczk et al., 1992; Shahidi
and Naczk, 1992; Vuorela, 2005).

Sources and derivatives of SA
SA is found in varying amounts primarily among citrus
fruits. For example, lemon and Murcott orange are known
to contain the highest quantities of SA in comparison to
other natural sources. Additionally, cereal grains such
as rye and rice are also known to contain substantial
concentrations of SA, while it has also been shown to be
present in various herbs such as sage and thyme. SA and
its derivatives are particularly abundant among the different
varieties of Brassica vegetables, including rapeseed, kale,
white cabbage, turnip and broccoli (Table 1). In terms
of its structure, SA is 3, 5-dimethoxy-4-hydroxycinnamic
acid, which is found either in free or esterified form. The
most common glycoside of SA is 1-O-β-d-glucopyranosyl
sinapate, which can be found in numerous Brassicaceae
species. SA can also form dimers with itself and ferulic
acid in the walls of cereal cells, with C8–C8-coupled SA
dehydrodimers and three sinapate-ferulate heterodimers
discovered in various insoluble and soluble cereal grain
dietary fibres. SA in rapeseed also exists as the glucosidic
ester, glucopyranosyl sinapate. SA does not usually
exist in free form, and <16% of SA is present as free SA.
Moreover, 4-vinylsyringol, which is found in crude rapeseed
oil, is a decarboxylation product of SA. During rapeseed oil
extraction, elevated temperatures and pressures cause SA
to undergo structural changes, resulting in the formation of
4-vinylsyringol, a decarboxylation product of SA, along with
syringaldehyde. The amount of SA derivatives (which include
sinapoyl glucose, methyl sinapate, sinapoyl malate and
1-sinapoyl-2-feruloylgentiobiose) found in rapeseed ranges
between 6,390 and 18,370 μg/g, but this is dependent on
the method used to process the oil (Lomascolo et al., 2012;
Nićiforović and Abramovič, 2014).
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Sources and structure of PCA
PCA is chemically known as 3,4-dihydroxybenzoic acid. This
compound is purported to have various pharmacological
activities, including anti-inflammatory, anti-cancer and
cardiac beneficial activity. It is frequently detected in edible
plants used in folk medicine and is one of the suggested
biologically active components in medicinal plants such as
Sudan Mallow (Hibiscus sabdariffa L.) and St. John’s wort
(Hypericum perforatum L.) (Kakkar and Bais, 2014). It is also
found in common fruits and vegetables, such as blackberries,
blackcurrant, cauliflower and lentils (Masella et al., 2012).
PCA is a major metabolite of other complex polyphenols, such
as the anthocyanins. Anthocyanins are mainly found in fruits
such as those of the berry family, pomegranate and pigmented
varieties of oranges (e.g. Tarocco, Moro and Sanguinello).
In humans and animals, anthocyanins are absorbed as
intact glycosides and metabolites. While they can undergo
methylation and glucuronidation, they primarily undergo
degradation, followed by considerable phase II conjugation,
particularly methylation and sulphation. De Ferrars et al.
(2014) studied the metabolism of the anthocyanin cyanidin3-glucoside and found that it spontaneously degrades to PCA
in the small intestine and the circulation (De Ferrars et al.,
2014).

Traditional extraction processes for recovering
phenolics from rapeseed meal
Traditionally, extraction of phenolic acids involves a defatting step to remove excess oil. This is usually performed
with hexane in a Soxhlet apparatus, with the use of food
grade hexane important if the product is to be utilised in food
applications. Phenolics found in rapeseed can be divided
into three categories: (1) free phenolic acids, (2) soluble
esters and (3) insoluble-bound phenolics (Naczk et al.,
1992; Szydłowska-Czerniak et al., 2010). Solvents used to
extract these phenolics include methanol, ethanol, acetone
or a combination of these (e.g. methanol: acetone: water
7:7:6) (Naczk et al., 1992; Cai and Arntfield, 2001; Khattab
et al., 2010; Liu et al., 2012). Free phenolic acids can be
extracted using methanol: acetone: water (7:7:6, v:v:v)
solvent system, and the soluble esters can be obtained
through hydrolysis with sodium hydroxide or enzymes and
subsequently extracted with diethyl ether: ethyl acetate (1:1,
v:v) (Naczk et al., 1992). Extraction and hydrolysis can also
be performed with enzymes, such as Ultraflo L and ferulic
acid esterase (Vuorela et al., 2003). The main compound
released using enzymatic extraction is SA, with a study by
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Vuorela (2005) revealing that enzymatic extractions yielded
a higher total phenolic content compared to solvent-based
extractions. Enzymes are also useful agents for isolation
in that they are considered food-friendly, which makes the
isolated compounds suitable for food applications (Vuorela,
2005).
Limitations of solvent extraction
Given the shift towards “green and sustainable” methods to
extract bioactive compounds, reducing or eliminating solvent
use is a key factor when developing new methodologies.
This is due to the harmful properties of organic solvents; they
are flammable, volatile and toxic, while they may also cause
environmental pollution (Chemat et al., 2012). The use of
organic solvents also poses problems in terms of using the
extracted compounds in food applications. In order for SA
and PCA to be used as food components, the solvents used
to extract them must be food grade and have safe status.
If solvents with toxic properties are used in the extraction
process, they must be removed to a specified residual
level in order to be eligible for use in food applications,
e.g. 5–30 mg of hexane/kg of product (such as edible oils)
(Starmans, 1996).

Novel extraction processes for recovering phenolics from rapeseed meal
Developing novel methods to isolate phenolic compounds
from rapeseed meal not only overcomes the issues
associated with the use of solvents but also closely links
with the biorefinery concept. Efficient, simpler and more
economic methods of isolation allow for the utilisation of
rapeseed by-products and ensure total utilisation of the crop,
with no or limited waste generation (Chemat et al., 2012).
Various novel methods to extract phenolic acids from various
natural product sources have been carried out to date,
including UAE, MAE, HVED and PEF extractions (Teh and
Birch, 2014; Barba et al., 2015; Teh et al., 2015).
UAE process
UAE provides a unique advantage over traditional methods
of extraction in that it can overcome physical barriers, such
as poor solubility of phenolics in rapeseed cake, which can
make extraction difficult. These physical barriers arise as
phenolics in the cake are encompassed in lignin, hulls and
cell walls, which are insoluble structures. This, along with
the fact that phenolic acids, including SA, occur as esters,
glycosides and insoluble-bound forms, has hindered their
extraction from rapeseed cake. Ultrasound generates sound
waves that create “cavitation bubbles” close to the sample
tissue; this leads to the breakdown and disruption of cell

walls and release of the bioactive contents (Khoddami
et al., 2013). Teh and Birch (2014) previously determined
the optimal parameters to extract phenolics from defatted canola seed cakes to comprise a 200 W ultrasound
extraction with a solvent volume of 50 mL, extraction time of
20 min, and temperature of 70°C. This method was found to
be advantageous over traditional methods in that it involves
low cost, has low solvent consumption and increases the
antioxidant activity of the extracts (Teh and Birch, 2014). Other
protocols have demonstrated UAE to be a suitable technique
to extract phenolics from rapeseed and related species. An
optimised protocol for the UAE of antioxidant compounds,
including phenolics, from rapeseed cultivars was previously
described by Szydłowska-Czerniak and Tułodziecka (2014).
They concluded that the optimal conditions to perform UAE
were an extraction time of 13.8 min, a solvent-to-material
ratio of 26.2 mL/g and a solvent concentration of 50.3%
(Szydłowska-Czerniak and Tułodziecka, 2014). Another
study investigated the optimal UAE conditions to extract
phenolics from kale, which is a member of the Brassicaceae
family, along with rapeseed. They determined that the
optimal conditions were 80% ethanol, with an extraction
time of 60 min, ultrasound frequency of 20 kHz and power of
100 W (Oniszczuk and Olech, 2016). Dubie et al. (2013) also
extracted phenolic antioxidant compounds from mustard
(Brassica juncea) seed meal, another member of the
Brassicaceae family, using UAE. They determined that the
optimal conditions were 75°C for 20 min with 70% ethanol
and a solvent-to-meal ratio of 40:1, with 20 kHz and 0.5 W/
mL ultrasound treatments using a Branson Sonifier probe
with input power of 400 W (Dubie et al., 2013).
MAE process
MAE of phenolics from rapeseed meal offers advantages,
including shorter extraction times and greater yields, over
traditional methods such as solvent extraction. Teh et al.
(2015) investigated MAE of phenolics from rapeseed cakes.
The optimal parameters for MAE of rapeseed cakes were
found to be 5 min, with a liquid: solvent ratio of 6 mL/g
and power of 633.33 W. Microwave pre-treatment using
the optimal parameters described maximised the phenolic
yield from rapeseed cake when subsequently extracted with
ultrasound and methanol: acetone: water mixture (7:7:6,
v:v:v). This method was economically viable due to the
shorter extraction time, moderate microwave power and low
electroporation voltage and frequency (Teh et al., 2015). MAE
has also been used in the extraction of phenolic compounds
from broccoli, which is a member of the Brassicaceae (or
mustard) family along with rapeseed. The optimal conditions
were determined to be 71.11°C, microwave power of
167.03 W, solvent concentration (methanol/water) of 75.95%
and an extraction time of 16.34 min (Jokić et al., 2012). Other

107

Irish Journal of Agricultural and Food Research

studies have demonstrated the efficacy of this technique
in the extraction of phenolics, although from different
sources, including rice grains and almond skin by-products
(Setyaningsih et al., 2015; Valdés et al., 2015). The success
of this technique in extracting phenolic compounds means
it could be a useful method to isolate phenolic compounds
from rapeseed meal, but further optimisation and validation
are necessary.
PEF extraction
PEF extraction is a process that does not require heat but
generates an electric field, which results in the electroporation
of the cellular membrane and the release of the bioactive
constituents from the “protoplasm”. The efficacy of this
technique depends on various factors, including the strength
of the electric field as well as the duration and number
of pulses. A recent study (Teh et al., 2015) optimised the
extraction of polyphenols using PEF from rapeseed cake.
In order to recover the maximum yield of polyphenols,
the optimal parameters for PEF extraction were found to
be as follows: voltage of 30 V, frequency of 30 Hz, 10%
ethanol and an exposure time of 10 s. This method also
proved advantageous over traditional methods due to the
shorter extraction time and low solvent use (Teh et al.,
2015). Yu et al. (2016) evaluated PEF-assisted extraction
of polyphenols in order to valorise a by-product of rapeseed
oil production, rapeseed stem or green biomass. They
determined that the number of pulses that yielded higher
total polyphenol content of juices pressed at 10 b was 200,
with a strength of 8 kv/cm. The efficacy of PEF pre-treatment
was demonstrated by the increase in total polyphenols with
PEF pre-treatment and subsequent pressing. Without PEF
pre-treatment, after 30 min of pressing, the result was 24%
polyphenol yield from rapeseed. PEF pre-treatment with
200 pulses and an increase in strength to 8 kv/cm resulted
in maximum polyphenol yield for pressing (Yu et al., 2016).
These initial studies have had success in isolating phenolics
from rapeseed by-products, and it could be a promising
novel method to isolate phenolic compounds; however,
further studies are necessary to fully validate this method
for use with rapeseed meal.
HVED approach
HVED is based on “electrical breakdown in water”, which
is accompanied by various phenomena including highamplitude pressure shock waves and cavitation bubbles.
This subsequently leads to the breakdown of cellular
structures and the release of the cell contents. The use
of HVED to isolate polyphenols from rapeseed cake was
also investigated previously (Barba et al., 2015). The study
found that when isolating polyphenols from rapeseed cake,
the liquid-to-solid ratio was a key parameter. The highest
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polyphenol content was observed using a liquid-to-solvent
ratio of 20, while a liquid-to-solvent ratio of either 5 or 20,
combined with HVED treatment at 80 kJ/kg also resulted in
increased polyphenol content. However, it was noted that
higher energy inputs >80 kJ/kg in rapeseed cake led to a
decrease in polyphenol content. The authors suggest that
high-energy inputs result in the creation of radicals, which in
turn decrease the polyphenol content (Barba et al., 2015).
Crucially, it was found that the extracts from rapeseed
cake had a significant increase in their antioxidant activity
following HVED treatments. Other studies have shown the
efficacy of this technique to extract phenolics from different
oilseed sources, including sesame cake and flaxseed cake
(Boussetta et al., 2013; Sarkis et al., 2015). The study by
Barba et al. was an initial optimisation, in addition to being
the first step in the search for more efficient methods to
isolate phenolic compounds from rapeseed by-products.
Further optimisation and validation are necessary in order
to ensure the efficacy of this novel technique; however, it is
worthy of mention due to its proven ability to extract phenolic
compounds and its apparent efficiency over traditional
methods, such as lower solvent consumption.

Characterisation strategies for rapeseed meal
phenolics
As SA and PCA found in rapeseed possess various bioactive
properties, including anti-inflammatory, anti-diabetes and
anti-cancer activities, they are of interest as functional food
components (Cherng et al., 2013; Del Corno et al., 2014; Tsao
et al., 2014). Therefore, further separation and purification are
necessary to isolate these phenolic compounds from the initial
fractions. Initially, the total phenolic content is often quantified
using the Folin-Ciocalteu assay (Vuorela, 2005). Chemical
characterisation and quantification are commonly performed
using high-performance liquid chromatography (HPLC) or
gas–liquid chromatography (GLC)/gas chromatography–mass
spectrometry (GC-MS) (Cai and Arntfield, 2001; Canini et al.,
2007; Khattab et al., 2010). HPLC is the preferred method
for separation and quantification of phenolic compounds
due to the fact that there is a wide range of commercially
available columns, as well as the potential to combine two
or more columns with differing column chemistries (Stalikas,
2007). However, despite the fact that HPLC is a commonly
used technique, it has been suggested that GC-MS is
more efficient, providing improved resolution and baseline
separation with minimum co-elution. It must also be noted
that when quantifying phenolic compounds with GC, there is
sometimes a requirement for chemical modification, such as
transformation to more volatile derivatives (Khoddami et al.,
2013).
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SA and PCA in human health and disease
Properties of SA
Antioxidant activity of SA
SA can modulate oxidative stress pathways in the cell and may
have potential in treating diabetes and high blood pressure
(Roy and Prince, 2012; Silambarasan et al., 2015). Oxidative
stress can be defined as an imbalance in the “redox” status
of a cell, which occurs when the levels of reactive oxygen
species (ROS) and antioxidants are unbalanced (Nordberg
and Arner, 2001). ROS can be found extrinsically in the form
of pollutants, tobacco smoke and radiation; however, ROS
may also be generated intrinsically through various pathways
in the mitochondria (Trachootham et al., 2009). The single
electron reduction of molecular oxygen leads to the formation
of a superoxide anion, a molecule that acts as a precursor
for the formation of most other ROS (Turrens, 2003). In order
to maintain homeostatic levels of reactive superoxide anions,
the mitochondrial matrix contains a family of metalloenzymes
known as superoxide dismutases (SODs). Compounds such
as ascorbic acid, tocopherols and glutathione (GSH) also
provide antioxidant activity (Jalaludeen and Pari, 2011). High
levels of ROS are known to be carcinogenic, damaging vital
cellular components including lipids, proteins and DNA. Given
the destructive potential of ROS, it is generally thought that the
use of antioxidants could reduce intracellular ROS levels and
thus alleviate ROS-mediated damage (Brieger et al., 2012).
Recent studies indicate the antioxidant activity of SA and SA’s
superoxide radical and hydroxyl radical, as well as its –O •scavenging activity (Zou et al., 2002; Jalaludeen and Pari,
2011). Using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay,
it was found that SA had higher free radical-scavenging activity
than its alkyl ester methyl sinapate or the control Trolox, a
vitamin E analogue. Ferric reducing antioxidant power (FRAP)
assays also revealed the higher antioxidant scavenging
activity of SA compared to its alkyl ester methyl sinapate or
the control Trolox (Gaspar et al., 2010). The mechanism and
kinetics of SA’s antioxidant activity were measured using its
hydroperoxyl radical (HOO•)-scavenging activity in lipidic and
aqueous solutions, which occurs through the transfer of a
hydrogen atom from its -OH group. The anionic form of SA at
physiological pH was also more reactive than its neutral form
towards oxygenated radicals (Galano et al., 2011).
2

Histone deacetylase inhibition
Histone deacetylases (HDACs) remove acetyl groups from
histones, resulting in a “closed” chromatin conformation that
blocks gene transcription and therefore gene expression.
Aberrant HDAC activity is common in various cancer types,
driving carcinogenesis through the repression of genes
involved in the cell cycle regulation, cellular differentiation

and apoptosis (Tortorella et al., 2015). Thus, HDAC inhibitors
are emerging as potential therapeutic agents. There has
been success in developing clinical therapeutics using
HDAC inhibitors from both natural and synthetic sources. For
example, suberoylanilide hydroxamic acid (SAHA) (vorinostat)
and the natural product, romidepsin, were both approved for
the treatment of cutaneous T-cell lymphoma (Mair et al., 2014).
SA was previously shown to have HDAC inhibitory activity.
Senawong et al. (2013) extracted phenolic compounds from
the rhizome of Hydnophytum formicarum Jack, and SA was
found to be one of the major components. SA was found to
block HDAC enzyme activity in vitro at a similar concentration
as the established HDAC inhibitor sodium butyrate, with the
authors suggesting that SA partly accounted for the HDAC
inhibitory activity of the phenolic extract. The phenolic extract
possessing HDAC inhibitory activity was found to inhibit the
growth of HeLa cells in a dose- and time-dependent manner,
while SA was also found to significantly inhibit the growth of
HT-29 cells. The phenolic extract and SA were also found to
have a significant effect on the induction of apoptosis, up to
78.9% and 8.4%, respectively.
Anti-cancer and antibacterial activities
SA was found to be cytotoxic against various cancer cell lines,
including the human colon cancer cell lines HT-29 and SW480
and the human laryngeal carcinoma Hep-2 cells, when
assayed previously (Balaji et al., 2014; Janakiraman et al.,
2014). The cytotoxicity is probably due to the anti-proliferative
activity of SA, which is supported by a study demonstrating
SA’s anti-proliferative activity against the breast cancer cell
line T47D (Kampa et al., 2004). The antibacterial effect of
SA was demonstrated to be anti-carcinogenic, brought about
by decreasing mucinase activity, an enzyme secreted by gut
microflora. This inhibited mucin degradation and enhanced
contact between carcinogens and colon epithelial cells. SA
also inhibited carcinogenesis by increasing the activities of
enzymatic and non-enzymatic antioxidants, including SOD,
catalase (CAT) and GSH, with ROS known to play a role in
early carcinogenesis. SA could potentially prevent the onset
of carcinogenesis, as demonstrated in a study by Balaji et al.
(2015). Colon cancer is the third most common malignancy
worldwide, with a high-fat diet being a primary risk factor for
developing colon cancer. Consumption of a high-fat diet has
been reported to increase the development of pre-neoplastic
lesions. Aberrant crypt foci (ACFs) are pre-neoplastic lesions,
which are formed during an early event in carcinogenesis in
humans and rodents. Rats fed a high-fat diet consisting of
peanut oil had increased crypt numbers and “multiplicity”. SA
supplementation in 1,2-dimethylhydrazine (DMH)-induced
colon cancer rats decreased the development and number
of ACFs. SA also decreased β-glucuronidase activity in
DMH-induced rats. Increased β-glucuronidase activity is
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considered a primary causative factor in colon cancer, via the
formation of methylazoxymethanol, a metabolite that induces
the formation of DNA adducts. SA was effective in reducing
the development of pre-cancerous lesions when studied
previously (Balaji et al., 2015).
Protective role in cardiovascular disease
Cardiovascular disease is the number one cause of death
globally and the leading cause of death among Europeans
(Townsend et al., 2015). The available figures from 2013
revealed that 30.8% of deaths in the US were due to
cardiovascular disease (Mozaffarian et al., 2016). Lifestyle
modifications, including a healthy diet, can play a protective
role. Although no human studies have been performed, SA
was shown to have a protective effect on isoproterenol (ISO)induced myocardial infarction (MI) in rats. MI induction with
ISO is a well-established animal model used to evaluate
the effects of various cardioprotective agents because
the pathophysiological changes are analogous to those
taking place in humans with MI. Pre- or co-treatment with
SA normalised the activity of serum creatine kinase (CKMB), suggesting that SA protects the heart and reduces
the damage leading to leakage of CK-MB. SA normalised
the levels of lipid peroxidation products, such as cardiac
malondialdehyde, and as such, apparently inhibited oxidative
stress and stabilised lysosomal membranes. In accordance
with this finding, SA normalised lysosomal enzymes including
β-glucuronidase and β-galactosidase, as well as cathepsins
B and D. Co-treatment with SA also reduced the size of the
infarct, protecting the heart from ISO-induced MI (Roy and
Prince, 2012).
Reperfusion injury occurs due to ischaemia followed by
reintroduction of blood flow to a previously ischaemic tissue,
causing additional myocardial damage and cardiac contractile
dysfunction (Silambarasan et al., 2015). As oxidative stress
is an important contributor to ischaemia/reperfusion (I/R)
injury, antioxidants have been considered as a potential
therapeutic option (Yang et al., 2013). Oral pre-treatment with
SA significantly improved the percent rate–pressure product
and percent coronary flow when compared to untreated I/R
hearts. Mitochondrial dysfunction results in cardiac contractile
dysfunction and hypertrophy; moreover, under conditions of
oxidative stress, the enzymes of the tricarboxylic acid (TCA)
cycle are disrupted. Decreases in the activity of several
TCA enzymes were blunted after pre-treatment with SA. SA
was also found to reduce H9c2 cardiomyoblast cell injury
caused by H O , probably due to its scavenging abilities
(Silambarasan et al., 2015).
In Nω–nitro-l-arginine methyl ester hydrochloride (l-NAME)treated rats, SA decreased the mean arterial pressure, along
with kidney and liver weights. SA increased the activities of
the antioxidant enzymes SOD and CAT, along with the levels
2
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of non-enzymatic antioxidants such as the vitamins C and
E. Ventricular hypertrophy was observed due to l-NAME
treatment, causing a reduction in contractile function. SA
treatment restored this ventricular function, which the
authors attributed to its antioxidant abilities, considering
that previous studies have shown that oxidative stress
plays a role in fibrosis during hypertension. Damaged cells
leak hepatic enzymes such as aspartate aminotransferase
(AST), alkaline phosphatase (ALP) and gamma-glutamyl
transferase (GGT), causing an increase in their activities.
Treatment with SA decreased their activities and controlled
liver damage, which was validated by histopathological
examination of the liver. SA was also found to decrease renal
function markers, including urea, uric acid and creatinine,
towards normal levels. Epidemiological studies have linked
hypercholesterolaemia to hypertension. Furthermore, SA
treatment was found to lower total cholesterol levels in the
liver and kidney of l-NAME spontaneously hypertensive
rats. Docking studies revealed that this effect was due to
the repression of endogenous cholesterol biosynthesis by
inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) reductase (Silambarasan et al., 2016).
Anti-diabetes activity
Diabetes is a group of “heterogeneous, hormonal and metabolic
disorders”, with hyperglycaemia being one of its physiological
characteristics. Type 2 diabetes (T2D), in particular, is one
of the most prevalent “metabolic pathologies” worldwide,
with >220 million people affected. Chronic hyperglycaemia
has detrimental cellular effects, as oxidation of glucose as
well as protein glycation and glycoxidation all enhance the
formation of ROS. The biochemical and physiological effects
of SA treatment on streptozotocin (STZ)-induced diabetic
rats revealed that oral administration of SA was found to
cause a significant improvement in body weight, attributed
to the anti-hyperglycaemic effect of SA (Stumvoll et al.,
2005). SA also influenced other physiological parameters,
such as decreasing kidney weight to near-normal values.
SA significantly decreased plasma glucose when compared
to diabetic control rats, which the authors suggest could be
due to the regeneration of existing pancreatic β-cells by SA
and enhanced transport of glucose to peripheral tissues.
SA significantly increased the levels of both C-peptide and
insulin in STZ-induced diabetic rats, while decreasing the
level of glycosylated haemoglobin (HbA1c) and increasing the
level of total haemoglobin. The authors speculate that these
changes could be due to the reduction of blood glucose level.
Increased activities of enzymes involved in gluconeogenesis,
i.e. glucose-6-phosphatase and fructose-1, 6-biphosphatase,
were observed in the liver and kidney of diabetic rats. SA
restored their level of activity to near normal, resulting in
improved glycaemic control (Kanchana et al., 2011).
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SA can directly influence glucose utilisation, by significantly
lowering postprandial glucose without altering plasma insulin
levels. Glucose transporter type 4 (GLUT4) expression was
significantly increased in the soleus muscle of STZ-induced
rats, with SA causing a concentration-dependent increase in
glucose uptake in the soleus muscle. This was confirmed in
L6 myoblast cells, indicating that SA may directly stimulate
glucose uptake. In vivo, SA increased insulin sensitivity,
probably due to the enhanced glucose uptake in skeletal
muscle (Cherng et al., 2013). Taken together, these results
indicate that SA may be clinically useful in the treatment of
diabetes.
Anti-inflammatory activity
Nuclear transcription factor kappa-B (NF-κB) plays a key
role in the pathogenesis of inflammation, and as such, there
are numerous drugs designed to treat inflammatory disease,
which are based on the inhibition of NF-κB, e.g. non-steroidal
anti-inflammatory drugs. In response to lipopolysaccharide
(LPS), SA inhibited the expression levels of inducible nitric
oxide synthase (iNOS) and cyclooxygenase (COX)-2, which
were markedly upregulated (Yun et al., 2008). The mRNA
levels of both iNOS and COX-2 were also reduced, indicating
transcriptional inhibition. SA reduced the production of tumour
necrosis factor (TNF)-α and interleukin (IL)-1β, as well as their
mRNA expression levels. RAW 264.7 cells treated with SA
had a reduction in the DNA-binding activity of p65, preventing
transcription initiation by NF-κB and subsequent expression
of genes involved in the immune response (Schmitz and
Baeuerle, 1991; Pahl, 1999). The nuclear translocation of
both p65 and p50 was also inhibited. Another key finding was
SA’s ability to inhibit the LPS-induced degradation of I kappa
B-alpha (IkB-α), preventing the release of NF-κB. These
results demonstrate that SA inhibits iNOS, TNF-α, COX-2 and
IL-1β expression, and this is at least partly mediated via an
NF-κB mechanism. This anti-inflammatory activity was also
demonstrated in vivo, with SA inhibiting oedema caused by
acute inflammation in serotonin- and carrageenan-induced rat
paw oedema models (Yun et al., 2008).
Properties of PCA
Antioxidant activity of PCA
The physiological effect of PCA is believed to be linked to
its antioxidant activities, which were recently investigated
in vitro. DPPH and 2,2′-azino-bis-3-ethylbenzthiazoline-6sulphonic acid (ABTS) assays demonstrated that PCA had
better scavenging activity than the positive controls Trolox
and butylated hydroxytoluene (BHT). When compared to
Trolox and BHT in terms of reducing power percentage (%Fe3+ and %-Cu2+), PCA was found to be much more efficient.
PCA also had lower half-maximal inhibitory concentration
(IC ) values for both Fe3+ and Cu2+ assays, in comparison to
50

Trolox and BHT. It was found that PCA generally exhibited
higher inhibition levels than Trolox, but not BHT, in terms of
scavenging of superoxide anion and hydroxyl radical. The
generally lower IC values obtained for PCA in comparison
to the positive controls Trolox and BHT indicate that PCA is
a better antioxidant, as a lower IC value indicates higher
antioxidant activity. The DPPH and ABTS assays were
conducted in organic solutions, while the reducing power
(Fe3+ and Cu2+) and superoxide anion- and hydroxyl radicalscavenging assays were carried out in aqueous solutions.
Therefore, PCA exhibited significant antioxidant abilities in
both lipidic and aqueous media and is thus considered an
ideal natural antioxidant in both media (Li et al., 2011). The
potent antioxidant activity of PCA was also shown in ageing
rats. Treatment with PCA caused a significant rise in the
enzymatic activities of CAT and GSH peroxidase (GSH-PX),
both of which are endogenous enzymatic antioxidants (Zhang
et al., 2011). This highlights the therapeutic potential for PCA
in the treatment of age-associated disorders, such as cancer,
through decreasing the levels of harmful ROS.
50

50

HDAC inhibition
Khaopha et al. (2015) obtained phenolic-rich testa extracts
from peanut testae (skins), which were found to possess
HDAC inhibitory activity and anti-cancer activity. PCA and
p-coumaric acid were found to be the most predominant
phenolic acids, with the highest quantity of PCA in the
ICG15042 extract, while SA was greater in the KK4
extract (Khaopha et al., 2015). HeLa cells treated with
the phenolic-rich testa extracts ICG15042, KS2 and KK4
displayed a significant increase in all four acetylated lysine
residues of histone H4, indicating HDAC inhibition. The
authors suggested that some of the phenolic compounds
in the extracts were functioning as HDAC inhibitors, with
extracts ICG15402 and KK4 chosen for further evaluation
as they displayed the highest HDAC inhibitory activity. Both
extracts significantly inhibited the proliferation of various
human cancer cell lines, including HeLa (human cervical
adenocarcinoma), HT29 (human colon adenocarcinoma),
HCT116 (human colorectal carcinoma) and Jurkat (human
T-cell leukaemia) cells, with Jurkat cells being particularly
sensitive to this anti-proliferative activity. Both extracts
induced apoptosis in the cancer cell lines; however, it
appeared that apoptotic induction was most effective in
the HeLa and HCT116 cells, a result also observed by
Senawong et al. (2013). Importantly, when the extracts were
tested with a non-cancer cell line, the number of apoptotic
cells was similar to that with the solvent control, indicating
that the phenolic extracts were not harmful to normal cells
(Khaopha et al., 2015). This is crucial given that specificity is
a vital attribute to any therapeutic agent, in order to minimise
damage to healthy cells and reduce side effects.
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Anti-cancer activity
Cytotoxicity
PCA is cytotoxic to various cancer cell lines, including
human breast MCF-7 cells, lung cancer A549 cell, HepG2
hepatocellular carcinoma, cervix HeLa and prostate cancer
LNCaP cells. PCA was able to penetrate the cancer cells,
destroying the integrity of the plasma membrane, causing
apoptosis and lactate dehydrogenase (LDH) leakage. PCA
also decreased Na+/K+-ATPase activity, thereby disrupting
ion homoeostasis, resulting in collapse of the mitochondrial
membrane. This collapse resulted in the release of proapoptotic factors, initiating the intrinsic apoptotic pathway,
and was also suggested to cause an increase in the activities
of caspase-8 and -3, which are key mediators of apoptosis
(Yin et al., 2009). PCA also displayed cytotoxicity against
non-small cell lung cancer via similar mechanisms as
reported herein. They found that PCA induced mitochondrial
dysfunction and apoptosis through increases in Bax and
caspase-3 expression and a decrease in Na+/K+-ATPase
activity. PCA also modulated several signalling pathways,
including FAK, MAPK and NF-κB pathways and thus reduced
the release of inflammatory cytokines such as IL- 6 and
IL-8. Production of proteins involved in metastasis (such
as basic fibroblast growth factor [bFGF] and the matrix
metalloproteinases MMP-2 and MMP-9) were also reduced
(Tsao et al., 2014).
Chemoprevention and reduced side effects
Cancer chemoprevention can be defined as the prevention
of cancer using non-toxic synthetic chemicals or chemicals
from natural substances before malignancy occurs. PCA was
previously shown to prevent oral carcinogenesis, reducing
incidences of neoplasms in the tongue (squamous cell
papilloma and carcinoma), along with significantly decreasing
pre-neoplastic lesions (hyperplasia and dysplasia) (Tanaka
et al., 1994). Anthocyanins derived from black raspberries,
along with the main anthocyanin metabolite PCA, were
studied in N-nitrosomethylbenzylamine (NMBA)-induced
oesophageal tumours in rats. PCA delayed the formation of
pre-neoplastic lesions and the progression of these lesions to
papillomas, ultimately reducing NMBA-induced oesophageal
carcinogenesis. PCA also induced the expression of PTX3,
which was shown to possess anti-angiogenic and antitumourigenic activity in prostate cancer cells (Peiffer et al.,
2014).
Although cancer prevention is crucial, improving existing
therapies and reducing harmful side effects is just as vital.
Cisplatin is widely used to treat various solid malignancies;
however, its use is limited due to its associated nephrotoxicity,
which primarily occurs in kidney proximal tubule epithelial
cells (Karasawa and Steyger, 2015). PCA was found to
prevent induced oxidative damage in kidney proximal tubule
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LLC-PK1 cells in vitro, while in vivo studies showed that PCA
prevented cisplatin-induced increase in the renal function
marker, creatine. Cisplatin treatment also resulted in distinct
histopathological changes in the rat kidney, such as tubular
epithelial cellular necrosis, desquamation, vacuolisation and
swelling. PCA treatment caused notable improvement in the
histological appearance, with reduced tubular cell damage
and swelling, providing almost “complete renoprotection”
(Yamabe et al., 2015).
Anti-metastatic activity
Metastasis accounts for almost 90% of cancer-associated
mortality and is the biggest problem in the clinical treatment
and management of cancer. PCA represents a potentially
important agent for those patients who are diagnosed with
early cancer lesions, as the anti-metastatic effects of PCA
could stop the subsequent dissemination from the primary
tumour and prevent metastasis in those patients (Chaffer
and Weinberg, 2011). The metastasis process is still poorly
understood, and there is an urgent need to develop new
therapeutic strategies and targets to prevent or inhibit
this phenomenon. The anti-metastatic potential of PCA in
the highly metastatic melanoma cell line B16/F10 and in
human gastric carcinoma AGS cells was also demonstrated
previously. PCA inhibited the secretion of MMP-2 in human
gastric carcinoma AGS cells and inhibited the protein kinase
B (Akt)/NF-κB/MMP-2 pathway via the activation of RhoB.
Metastasis of the B16/F10 melanoma cells to the liver of C57/
BL6 mice was also considerably reduced by PCA treatment
(Lin et al., 2011).
Anti-inflammatory activity
Studies have demonstrated the ability of PCA to inhibit the
LPS-induced secretion of pro-inflammatory cytokines, such
as IL-8, IL-2 and chemokine (C-C motif) ligand-2 (CCL2),
from monocyte-derived dendritic cells and human gingival
fibroblasts via activation of peroxisome proliferator-activated
receptor (PPAR)-g. As cytokines such as IL-8 and CCL2 are
involved in recruiting inflammatory cells, a reduction in the
IL-8 content in the extracellular environment may limit the
recruitment of inflammatory cells and thus prevent the initiation
of an inflammatory immune response (Del Corno et al., 2014;
Wang et al., 2015b). PCA can also prevent inflammation by
inhibiting the oxidation of fatty acids, which are activators
of PPAR-g signalling (Nagy et al., 1998). The pathology
of neurodegenerative diseases, including Parkinson’s
and Alzheimer’s disease (AD), has been attributed to the
overproduction of inflammatory mediators such as TNF-α,
IL-6 and IL-1β. These inflammatory mediators are produced
following the activation of microglia, which are immune cells
resident in the brain, by LPS, and the subsequent activation
of NF-κB and MAPKs. As such, regulating the activity of
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the microglia could be a potential therapeutic strategy. In
accordance with this observation, Wang et al. (2015) found
that PCA could inhibit the inflammatory mediators TNF-α, IL1β, IL-6 and prostaglandin-2 (PGE2) but could also inhibit
the LPS-induced activation of NF-κB and MAPKs, both of
which are key regulators of inflammatory cytokine production.
Another key finding was PCA’s ability to inhibit the expression
of Toll-like receptor 4 (TLR4), a receptor that activates NFκB and MAPKs upon stimulation by LPS. This, therefore,
suggests that PCA exerts its anti-inflammatory effects
through inhibition of the TLR4 pathway, making it a potential
candidate to regulate the activation of microglia in order to
treat neurodegenerative diseases (Wang et al., 2015a).
A recently published study has identified PCA as a potential
therapeutic agent in the treatment of inflammatory bone
disease. Osteoclasts are necessary for bone matrix
degradation and to initiate bone re-modelling. However, an
imbalance in their activity can lead to bone deterioration,
which is a symptom of diseases such as osteoporosis and
rheumatoid arthritis. M-CSF and RANK-L are potent inducers
of mature osteoclasts, with RANK-L activating transcription
factors such as c-Fos, which activate osteoclasts and induce
their differentiation. PCA was found to inhibit RANK-L-induced
c-Fos protein expression, while also inhibiting the differentiation
of osteoclasts in mouse bone marrow macrophages. The
bone-resorbing ability of mature osteoclasts was also inhibited.
In vivo, PCA was shown to have a protective effect against
LPS-induced bone loss. PCA was also found to downregulate
the expression of osteoclastogenesis-related genes, including
DC-STAMP and b3-integrin (Park et al., 2016b).
Protective role in cardiovascular disease
The co-morbidities associated with diabetes pose serious
health risks, with vascular complications being the primary
cause of mortality and morbidity in those suffering from
chronic diabetes. The effects of PCA on vascular responses in
chronically diabetic rats were also examined. PCA was found
to protect blood vessels by increasing nitric oxide production,
which prevents the interaction of platelets and leucocytes with
the vascular cell wall. Hypertension is a common complication
of diabetes. PCA was found to cause significant reductions in
the high diastolic, systolic and mean arterial blood pressures
observed in chronically diabetic rats. PCA also ameliorated
diabetes-induced high blood pressure by restoring the
reduced vascular reactivity in the diabetic rats (Semaming
et al., 2016). This improved reactivity was exemplified by the
restoration of the vasoconstriction and vasodilation responses
following PCA treatment. PCA treatment also caused a
decrease in the oxidative stress marker malondialdehyde
(MDA), while the activities of the antioxidant enzymes SOD
and CAT were increased. The authors, therefore, suggested
that the improved vascular reactivity observed in the diabetic

rats could be due to the antioxidant activity of PCA, given that
it has been postulated that oxidation plays a role in vascular
impairment in diabetes. The potential of PCA to prevent or limit
cardiac complications in diabetes was demonstrated earlier
using type 1 diabetic rats by Semaming et al. (2014), who
found that PCA reduced MDA levels, along with attenuating
mitochondrial depolarisation, decreasing mitochondrial
swelling and attenuating mitochondrial ROS production. PCA
in combination with insulin could restore echocardiography to
a normal status, which could not be achieved by insulin alone.
HbA1c levels were also reduced, indicating greater long-term
glycaemic control. Cardiac apoptosis is a poor predictor of
outcome in those with cardiac disease or heart failure. In line
with this, PCA increased the anti-apoptotic protein Bcl2 in the
heart tissue of diabetic rats (Semaming et al., 2014).
Currently, there is a need for anticoagulation agents from
natural sources in the clinic. In addition, the anti-thrombotic
potential of PCA derived from fermented pine needles was
evaluated. The processes of coagulation and anticoagulation
are tightly regulated, and an imbalance in this process can
lead to thrombus formation, which adheres to blood vessel
walls. If this thrombus is not broken down, circulation is
interrupted, leading to high blood pressure, stroke, ischaemic
heart disease and myocardial infarction. PCA was tested for
its fibrinolysis activity, by measuring the turbidity in a fibrin
clot solution. PCA caused a dramatic decrease in turbidity,
indicating that the fibrin clot had dissolved. Further studies
aimed to elucidate the mechanism behind the fibrinolytic
activity of PCA. A pH range of 2–4 was optimal for PCA to exert
its fibrinolytic activity. At this acidic pH, PCA mainly exists in a
non-ionised form, therefore allowing it to form greater number
of hydrophobic interactions. The authors suggested that this
increased tendency towards hydrophobic interactions allows
enhanced binding between PCA and polypeptide chains,
compromising their stability and causing “loosening of the
fibrin network”. The authors concluded that PCA exerted its
fibrinolytic activity through a “dissolving effect”, rather than by
degradation of fibrin and fibrinogen. In vivo, PCA was shown
to significantly inhibit thrombosis induced by carrageenan in
mouse tail when compared to the control. In FeCl -induced
carotid arterial thrombus model experiments, rats treated with
PCA had no thrombus formation, indicating that PCA could
inhibit vascular obstruction (Park et al., 2016a).
3

Anti-diabetes activity
Functional foods provide a promising alternative therapeutic
strategy to drive positive metabolic changes that would impair
the T2D process; however, few studies have elucidated the
molecular mechanisms of polyphenols on insulin signalling. A
recent study (Scazzocchio et al., 2011) has shown that PCA
is able to partially counteract the loss of insulin sensitivity
in T2DM and activate the insulin receptor substrate-1/
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phosphatidylinositol 3-kinase/Akt (IRS-1/PI3K/Akt) signalling
pathway, leading to increased glucose uptake. In adipocytes,
PCA was found to be dependent on activation of the entire
insulin pathway, as inhibition of the major players in the
insulin signalling cascade IRS-1, PI3K or Akt prevented
glucose uptake and GLUT4 translocation. PCA has also
been reported to enhance glucose uptake by increasing
translocation of GLUT4 to the cell membrane or, additionally,
by increasing adiponectin secretion, a protein hormone
capable of modulating glucose and fatty acid metabolism
(Scazzocchio et al., 2011).
The effects of PCA on adenosine monophosphate (AMP)activated protein kinase (AMPK) activation and the role
of PCA in glucose homoeostasis in mice were examined
previously (Talagavadi et al., 2016). AMPK is involved in
metabolic regulation and was reported to be central to the
control of glucose metabolism. In contrast, mammalian target
of rapamycin (mTOR) and S6K1 are known to play a role in
insulin resistance. It was found that PCA could significantly
activate AMPK, although indirectly, and downregulate S6K in
mouse livers. Upon intraperitoneal administration of glucose,
there was a significant decrease in the glucose level in PCAtreated mice, with similar results obtained for the positive
control metformin, indicating that PCA can induce glucose
tolerance. In obese mice, pre-treatment with PCA significantly
reduced hyperglycaemia after glucose injection. Furthermore,
the insulin tolerance test showed that PCA administration
amplified the glucose decrease, indicating that PCA improved
insulin sensitivity in obese mice (Talagavadi et al., 2016).
Protective neurological effects
In order to repair injured nerves in adults, proliferation of
nerve cells is a vital process. Schwann cells are crucial
for the function and regeneration of neurons, and it was
recently demonstrated that PCA could stimulate Schwann
cell proliferation and survival by phosphorylating the insulinlike growth factor-I (IGF-I)-mediated PI3K/Akt pathway (Ju
et al., 2015). PCA enhanced the proliferation of RSC96 cells,
inducing cell cycle progression at the G1-to-S phase. An
increase in cyclin A was observed, resulting in the promotion
of DNA replication and growth of RSC96 cells. A phenomenon
that is vital to the repair and regeneration process of nerves
is the migration of RSC96 Schwann cells along the growth
direction. It was found that PCA enhanced Schwann cell
migration, and that the IGF-1/Akt/PI3K pathway may play a
key role in this process. The results of that study highlight the
potential utility of PCA in the treatment of peripheral nerve
injuries caused by trauma, surgery or acute compression.
Guan et al. (2009) also demonstrated the ability of PCA to
stimulate proliferation of rat hippocampal neural stem cells,
which are believed to contribute to the regenerative potential
of the adult central nervous system.
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For patients suffering from neurodegenerative brain diseases,
ameliorating symptoms is crucial. PCA was found to improve
cognitive defects in a mouse model of AD and attenuate Ab
deposition, which is a hallmark of AD (Song et al., 2014).
Inflammatory events in AD result from an imbalance in the
formation and clearance of Ab, with mounting evidence that
Ab accumulation is linked to the secretion of inflammatory
cytokines. PCA reduced the levels of TNF-α, IL-1β, IL-6 and
IL-8 in AbPP/PS1 mice. Although the underlying mechanism
behind PCA’s effect on Ab-induced neurotoxicity was
not elucidated, it is attributed to its antioxidant and antiinflammatory activities. Crucially, PCA displayed similar antiinflammatory activity as donepezil, a cholinesterase inhibitor
used to treat AD.
Protection against nephrotoxicity and hepatotoxicity
Cadmium (Cd) is a heavy metal that is a by-product of zinc
production. It is considered to be one of the most toxic
environmental and industrial pollutants. It can be ingested
from foods, drinking water and contaminated soil or through
cigarette smoking. The kidney is the most affected by
prolonged low-level exposure to Cd, causing proteinuria,
calciuria and tubular necrosis, all of which may result in endstage renal failure, diabetic complications and osteoporosis.
Cd can also lead to nephrotoxicity due to its tendency to settle
in the proximal tubule of the nephron, although the underlying
mechanism is yet to be fully elucidated. PCA can attenuate
the nephrotoxicity and hepatotoxicity induced by Cd in rats.
Treatment with Cd led to “severe” hepatic damage, evidenced
by the increased activity of the hepatic enzymes alanine
transaminase (ALT), AST and ALP in the serum of the Cdinduced hepatotoxicity group compared to the normal control.
Co-treatment with PCA was found to ameliorate the activities
of these hepatic enzymes. Crucially, PCA at doses of 10 and
20 mg/kg had no adverse effects on the rats (Adefegha et al.,
2015).

Potential use of SA and PCA recovered from rapeseed meal
SA and PCA may improve human health, and both
compounds are present in traditional Chinese medicines,
such as “Yinhuang powder” and Salvia miltiorrhiza (also
known as Danshen) (Wen et al., 2005; Cao et al., 2014; Su
et al., 2015). Research on these phenolic compounds has
suggested that they possess diverse bioactive properties,
including anti-cancer, anti-diabetes and anti-inflammatory
activities, in addition to a role in the prevention and treatment
of cardiovascular and neurodegenerative diseases (Yun
et al., 2008; Balaji et al., 2015; Ju et al., 2015; Semaming
et al., 2016; Talagavadi et al., 2016). Given these potent
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bioactivities and the fact that rapeseed is a rich source of
phenolic compounds, optimising methods to isolate these
compounds from rapeseed meal is pertinent. SA and PCA
in dietary sources are present in insufficient quantities to
exert a sufficient physiological effect (Nunez-Sanchez et al.,
2015). Therefore, optimal extraction of these phenolics from
rapeseed meal would allow them to be used as functional
food ingredients and exert their physiological effects through
dietary intake. The antioxidant properties of these phenolics
would make them useful in the cosmetic industry, and indeed,
a patent was filed regarding the use of SA as a cosmetic
ingredient, such as in a topical agent to protect against the
signs of skin ageing (Markert et al., 2011).

Bottlenecks concerning the use of SA and PCA recovered from rapeseed meal
The stability and bioavailability of rapeseed phenolics is an
issue in terms of the biorefining process and total utilisation
of the rapeseed crop (Nićiforović and Abramovič, 2014;
Dias et al., 2015). Phenolic compounds are susceptible to
spontaneous oxidation and degradation (Tan et al., 2011).
Oxidation may occur through enzymatic or non-enzymatic
reactions, resulting in oxidation products that are “nutritionally
unavailable” (Shahidi and Naczk, 1992). Phenolics can also
interact with minerals, such as iron, and inhibit their absorption,
and the metabolism of phenolics by phase II enzymes also
leads to poor bioavailability (Vuorela, 2005; De Souza et al.,
2015). Bioavailability is a key issue, given that little is known
about the metabolism of SA and PCA. The epithelium of the
small intestine plays a role in the bioavailability and metabolism
of SA, involving both phase I and phase II metabolic enzymes;
however, compared to other hydroxycinnamic acids such
as ferulic acid, little is known about the metabolism of SA
(Nićiforović and Abramovič, 2014). A recent bioavailability
study with rats fed the herb Polygonum capitatum found that
PCA was primarily distributed in the kidney tissue, followed
by the lung tissue; however, >80% was excreted (Ma et al.,
2016). PCA was not detected in the brain, indicating its
inability to cross the blood–brain barrier; this is in contrast with
a study by Guan et al. (2009), who detected PCA in rat brain
micro-dialysates, indicating that it could cross the blood–brain
barrier.
As such, validation of this rapeseed by-product requires
stabilisation of the phenolic compounds before application in
either food or cosmetics. Indeed, a patent regarding use of SA
for cosmetics, including as a topical composition to reduce the
signs of ageing, noted the instability of SA and proposed microencapsulation as a solution (Markert et al., 2011). Nanoparticleand microparticle-based delivery systems provide a potential
solution to the problem of reduced stability and bioavailability

of phenolics, including SA and PCA. Such systems were
found to increase the phytochemical absorption of phenolic
compounds in epithelial cells (Dias et al., 2015). The increased
bioavailability of resveratrol following micro-encapsulation is
proof of the efficacy of this technique (Davidov-Pardo and
McClements, 2014). Utilising SA and PCA as functional food
ingredients allows validation of a rapeseed by-product and
its potent bioactive phenolics. Phenolic compounds have
previously been encapsulated using methods such as spraydrying, extrusion and atomisation/coagulation. Spray-drying
is a very straightforward and common micro-encapsulation
method used in the food industry. Carbohydrate polymers
such as starch and cellulose are commonly used as the
shell material and are good candidates as they are generally
recognised as safe (GRAS) (Dias et al., 2015). A recent in
vitro study demonstrated the great potential to successfully
encapsulate PCA for functional food purposes. Madureira et al.
(2016) investigated chitosan nanoparticles “loaded” with PCA
for potential incorporation into food matrices or as functional
food ingredients. The study found that the best nanoparticle
for PCA was a low-molecular-weight nanoparticle, and the
encapsulation process did not diminish the antioxidant activity
of PCA. It was found that the nanoparticles could bypass
the acidic environment of the stomach intact and reach
the intestine, where the neutral pH results in “coagulation/
flocculation” of the chitosan nanoparticle and release of the
phenolics. From the intestine, the phenolics can be absorbed
into the bloodstream (Madureira et al., 2016). Ultimately,
validating this rapeseed by-product and its bioactive
compounds for use in food, cosmetic and pharmaceutical
industries depends on successful clinical trials. Currently,
there are no clinical studies examining the bioavailability or
bioactivity of phenolic acids from rapeseed, including SA and
PCA. However, a search of Clinicaltrials.gov revealed that
there have been trials on phenolic acids from other sources
such as black tea, oat and purple wheat products in terms of
their pharmacokinetics and bioavailability.

Conclusion
Phenolic compounds such as SA and PCA hold great
promise due to their purported bioactive properties,
including anti-diabetes, anti-cancer and anti-inflammatory
activities, in addition to possessing a protective role in AD
and cardiovascular disease. Various traditional methods are
used to extract these phenolics from rapeseed meal, based
on both solvents and enzymes. However, there are issues
associated with these methods, including the requirement
for large volumes of solvents and their associated toxicities.
The need for simpler, more efficient methodologies has led
to the development of novel techniques, such as ultrasound-
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assisted, microwave-assisted, HVED and PEF extractions.
Development of these novel techniques allows the validation
of a rapeseed by-product and total utilisation of the rapeseed
crop without generating waste. It must be noted that further
optimisation and validation of these techniques are necessary
with regard to isolating phenolic compounds from rapeseed
meal.
In order to utilise the phenolic compounds isolated from
rapeseed meal, there are issues that need to be addressed.
The two major issues are stability and bioavailability, which
could hinder the use of the phenolics in food and cosmetic
industries. A solution is the micro-encapsulation of the
phenolics, and initial studies have shown the efficacy of
this technique, which would make the phenolics suitable
for food applications. Ultimately, maximising the use of
rapeseed meal phenolics depends on proven clinical safety
and efficacy. To date, there are no clinical trials regarding
rapeseed phenolics, including SA and PCA; however, there
are clinical trials regarding the use of phenolic compounds
from other sources.
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